Synlogic Reports Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the third quarter 2024 and provided a corporate update.
Read more at globenewswire.com
